Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
Introduction: The endothelial glycocalyx degrading enzyme heparanase-1 (HPSE1) is a major contributor to kidney diseases, such as glomerulonephritis and diabetic nephropathy. Therefore, inhibition of HPSE1 could be an interesting therapeutic strategy to treat glomerular diseases. A possible HPSE1 in...
Saved in:
Main Authors: | Baranca Buijsers (Author), Marjolein Garsen (Author), Mark de Graaf (Author), Marinka Bakker-van Bebber (Author), Chunming Guo (Author), Xue Li (Author), Johan van der Vlag (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of heparanase in pulmonary hypertension
by: Lin-Jun Wang, et al.
Published: (2023) -
Role of heparanase in ARDS through autophagy and exosome pathway (review)
by: Fei Feng, et al.
Published: (2023) -
Membranoproliferative glomerulonephritis: A rare pediatric nephropathy
by: Andreia Marinhas, et al.
Published: (2022) -
Evaluation of Immunohistochemical Expression of Heparanase in -Associated Chronic Gastritis
by: Sheren Farrag Mahmoud Ahmed, et al.
Published: (2023) -
Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
by: Maria Aparecida Silva Pinhal, et al.
Published: (2016)